Breaking News Instant updates and real-time market news.

APRN

Blue Apron

$2.50

-0.01 (-0.40%)

, SBUX

Starbucks

$56.52

-0.62 (-1.09%)

12:59
05/15/18
05/15
12:59
05/15/18
12:59

Consultant believes Starbucks should buy Blue Apron, RetailWire says

Consultant Brittain Ladd makes the case that Blue Apron's (APRN) recently announced partnership with Costco (COST) is "a poor move" and he believes that an acquisition by Starbucks (SBUX) would be "Blue Apron's real meal ticket," according to RetailWire. Reference Link

APRN

Blue Apron

$2.50

-0.01 (-0.40%)

SBUX

Starbucks

$56.52

-0.62 (-1.09%)

COST

Costco

$196.16

0.31 (0.16%)

  • 15

    May

  • 18

    May

APRN Blue Apron
$2.50

-0.01 (-0.40%)

02/02/18
02/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. VF Corp. (VFC) initiated with an Overweight at Barclays. 2. JinkoSolar (JKS) initiated with a Sell at Vertical Group. 3. Chimerix (CMRX) initiated with a Buy at H.C. Wainwright. 4. Voyager Therapeutics (VYGR) initiated with an Overweight at Morgan Stanley. 5. Blue Apron (APRN) initiated with a Buy at Gabelli. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/18
ADAM
02/14/18
NO CHANGE
Target $8
ADAM
Buy
Blue Apron showing signs of stabilization, says Canaccord
Canaccord analyst Michael Graham said Blue Apron's Q4 results were generally inline with expectations, with EBITDA better than expected. The analyst said Blue Apron has had its share of challenges since its IPO, but he is cautiously optimistic given its low valuation, the resumption of marketing spending, reduced capex requirements, and the potential for partnerships and product expansion. Graham maintained his Buy rating and lowered his price target to $8 from $10 on Blue Apron shares.
02/16/18
NRCS
02/16/18
UPGRADE
NRCS
Neutral
Blue Apron upgraded to Neutral from Sell at Northcoast
02/16/18
02/16/18
UPGRADE

Neutral
Blue Apron upgraded to Neutral on retail partnership potential at Northcoast
As previously reported, Northcoast analyst Charles Cerankosky upgraded Blue Apron to Neutral from Sell. He noted that management is suggesting the company could be at breakeven EBITDA by year end, though he "is far less optimistic." Still, given the pressure of its negative cash flow, he thinks Blue Apron will explore a retail distribution partnership, which could have a potential headline benefit. However, Cerankosky added that he expects that even if such a retail distribution partnership was struck, he believes "disappointing sales at retail would likely force such a relationship to die quickly."
SBUX Starbucks
$56.52

-0.62 (-1.09%)

04/27/18
PIPR
04/27/18
NO CHANGE
Target $70
PIPR
Overweight
Piper reiterates Overweight rating on Starbucks with $70 price target
Starbucks' fiscal Q2 results, while a "lackluster performance on the surface," is more reflective of what is being done versus the prior-year period, Piper Jaffray analyst Nicole Miller Regan tells investors in a research note. The up 2% Americas comp was a highlight, while store-level margins down 220 basis points to 20% of sales is concerning to most investors, the analyst adds. She believes the May 16-17 analyst day should serve as a positive catalyst, but cautions that domestic comps "likely overshadow this from a near-term stock perspective." Regan's bull case model suggests 14% earnings growth is sustainable. She reiterates an Overweight rating on Starbucks with a $70 price target.
05/08/18
MSCO
05/08/18
NO CHANGE
Target $72
MSCO
Overweight
Starbucks packaged deal with Nestle a long-term positive, says Morgan Stanley
Morgan Stanley analyst John Glass called Starbucks' (SBUX) packaged coffee deal with Nestle (NSRGY) a long-term positive, noting that it opens up previously untapped markets and improves the business' growth profile. The deal should be dilutive in FY19 and accretive by FY21, added Glass, who has an Overweight rating and $72 price target on Starbucks shares.
04/27/18
OPCO
04/27/18
NO CHANGE
Target $66
OPCO
Outperform
Oppenheimer reiterates Outperform rating on Starbucks with $66 price target
Oppenheimer analyst Brian Bittner reiterated an Outperform rating and $66 price target on Starbucks following the company's in-line Q2 results. In a research note to investors, Bittner said the drivers discussed to elevate comparable sales are more likely to impact 2019 performance than 2018. Despite this, he sees limited downside risk to 2018 EPS estimates if comps stay at about 2% in the second half of the year and sees an improving risk/reward into fiscal 2019.
04/13/18
04/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) downgraded to Market Perform from Outperform at Cowen with analyst Andrew Charles saying his optimism about a comparable sales rebound in the Americas region is diminished as he sees intensified craft coffee competition along with expressing uncertainty on the timeline and magnitude of success with its loyalty efforts. 2. Diamond Offshore (DO) downgraded to Underperform from Neutral at Credit Suisse. 3. Zillow (Z, ZG) downgraded to Hold from Buy at Craig-Hallum with analyst Brad Berning citing the company's announcement that it is expanding its Instant Offers program to Phoenix in addition to Las Vegas and Orlando. 4. Nu Skin (NUS) downgraded to Hold from Buy at Deutsche Bank with analyst Steve Powers saying with the valuation at multi-year highs, the market is pricing in a "material acceleration" in sales and earnings trends. 5. Tenneco (TEN) downgraded to Neutral from Buy at Goldman Sachs with analyst David Tamberrino saying he sees the strategic rationale in the Federal-Mogul acquisition, but highlights near-term challenges from input costs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COST Costco
$196.16

0.31 (0.16%)

04/16/18
WELS
04/16/18
UPGRADE
Target $220
WELS
Outperform
Costco upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Edward Kelly upgraded Costco Wholesale to Outperform and raised his price target for the shares to $220 from $195. The analyst expects Costco to "sustain strong comp momentum" despite difficult comparisons, deliver improved membership trends, navigate rising retail cost pressures, and beat consensus expectations. The stock "looks to be on the cusp of its next leg up," Kelly tells investors in a research note. The analyst notes that while the current valuation is "high," it remains "well below peak levels."
04/16/18
04/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Costco (COST) upgraded to Outperform from Market Perform at Wells Fargo with analyst Edward Kelly saying he expects Costco to "sustain strong comp momentum" despite difficult comparisons, deliver improved membership trends, navigate rising retail cost pressures, and beat consensus expectations. 2. Boston Beer (SAM) upgraded to Neutral from Sell at Goldman Sachs. 3. Ulta Beauty (ULTA) upgraded to Buy from Neutral at Guggenheim with analyst Steven Forbes saying he believes Ulta's industry-leading position and secular growth potential is undervalued with shares trading at 10x 2019 EBITDA. 4. Nielsen (NLSN) upgraded to Outperform from Market Perform at BMO Capital with analyst Daniel Salmon saying the heightened regulation on open internet platforms is a positive for a company involved with measurement and verification of data, which could increase demand for its products. 5. C.H. Robinson (CHRW) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying trends in the first quarter are very favorable, which points to strong Q1 results for the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/18
UBSW
05/03/18
NO CHANGE
Target $215
UBSW
Buy
Costco shares remain compelling, says UBS
UBS analyst Michael Lasser met with Costco (COST) management, who noted their prices are well below Amazon's (AMZN) and at an even steeper discount to Whole Foods. He said Costco's model continues to stand on its own and he believes the shares are compelling at current levels. Lasser reiterated his Buy rating and $215 price target on Costco shares.
04/12/18
BARD
04/12/18
NO CHANGE
Target $215
BARD
Outperform
Costco March traffic remained robust, sales impressive, says Baird
Baird analyst Peter Benedict said the traffic for Costco remained robust and the company posted impressive same store sales in March. He said the results underscore the durability and relevancy of its business model and he remains a buyer of the shares. Benedict reiterated his Outperform rating and $215 price target on Costco shares.

TODAY'S FREE FLY STORIES

KORS

Michael Kors

$68.71

0.33 (0.48%)

12:45
05/25/18
05/25
12:45
05/25/18
12:45
Options
Michael Kors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 26

    Jun

12:45
05/25/18
05/25
12:45
05/25/18
12:45
General news
Breaking General news story  »

Week of 5/25 Baker-Hughes…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, ACIA

Acacia Communications

$33.68

1.49 (4.63%)

12:39
05/25/18
05/25
12:39
05/25/18
12:39
Periodicals
Trump administration says deal struck on ZTE Corp., NYT reports »

The Trump administration…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

ACIA

Acacia Communications

$33.68

1.49 (4.63%)

OCLR

Oclaro

$9.13

0.25 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 12

    Jun

  • 10

    Sep

NBR

Nabors Industries

$7.27

-0.54 (-6.91%)

12:35
05/25/18
05/25
12:35
05/25/18
12:35
Options
Nabors Industries put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$100.19

0.01 (0.01%)

12:31
05/25/18
05/25
12:31
05/25/18
12:31
Hot Stocks
PepsiCo confirms agreement to acquire Bare Snacks »

PepsiCo announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$100.29

0.11 (0.11%)

12:29
05/25/18
05/25
12:29
05/25/18
12:29
Periodicals
PepsiCo to acquire baked fruit and veggie snack maker Bare Foods, NYT reports »

PepsiCo will acquire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$55.19

0.41 (0.75%)

12:27
05/25/18
05/25
12:27
05/25/18
12:27
Periodicals
EEOC investigates age discrimination claims against Intel, WSJ reports »

The U.S. Equal Employment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$77.43

-5.52 (-6.65%)

12:20
05/25/18
05/25
12:20
05/25/18
12:20
Options
Notable ratio spread in Ross Stores as shares slump on earnings »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.45

-4.52 (-13.71%)

, FL

Foot Locker

$53.39

7.01 (15.11%)

12:18
05/25/18
05/25
12:18
05/25/18
12:18
General news
On The Fly: Top stock stories at midday »

The S&P 500 opened…

GPS

Gap

$28.45

-4.52 (-13.71%)

FL

Foot Locker

$53.39

7.01 (15.11%)

HLF

Herbalife Nutrition

$48.96

-4.89 (-9.08%)

IEP

Icahn Enterprises

$69.33

0.14 (0.20%)

FCAU

Fiat Chrysler

$21.86

-0.4 (-1.80%)

DGX

Quest Diagnostics

$106.60

5.71 (5.66%)

UNH

UnitedHealth

$244.87

2.14 (0.88%)

ROST

Ross Stores

$77.38

-5.57 (-6.71%)

ADSK

Autodesk

$132.89

-5.87 (-4.23%)

AAL

American Airlines

$45.31

1.76 (4.04%)

LUV

Southwest

$53.21

2 (3.91%)

DAL

Delta Air Lines

$55.80

1.39 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
05/25/18
05/25
12:17
05/25/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$162.03

-0.01 (-0.01%)

, DIA

Diamonds Fund ETF

$247.61

-0.29 (-0.12%)

12:16
05/25/18
05/25
12:16
05/25/18
12:16
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, fund flows…

IWM

iShares Trust Russell 2000 Index Fund

$162.03

-0.01 (-0.01%)

DIA

Diamonds Fund ETF

$247.61

-0.29 (-0.12%)

XLF

Financial Select Sector

$27.87

-0.08 (-0.29%)

XLE

Energy Select Sector SPDR

$74.03

-2.51 (-3.28%)

IVV

iShares Core S&P 500

$274.29

-0.46 (-0.17%)

SPY

SPDR S&P 500 ETF Trust

$272.41

-0.46 (-0.17%)

JNK

SPDR Barclays High Yield Bond

$35.72

-0.03 (-0.08%)

EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$109.63

0.28 (0.26%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.29

0.235 (0.20%)

EFV

iShares MSCI EAFE Value ETF

$54.37

-0.49 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
05/25/18
05/25
12:16
05/25/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$12.00

-1.04 (-7.98%)

12:15
05/25/18
05/25
12:15
05/25/18
12:15
Options
QEP Resources put volume heavy and directionally bearish »

Bearish flow noted in QEP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

AIPT

Precision Therapeutics

$1.00

0.01 (1.01%)

, SKLN

Ticker changed to AIPT

$0.00

(0.00%)

12:10
05/25/18
05/25
12:10
05/25/18
12:10
Hot Stocks
Skyline Medical says products approved on DAPA contract »

Skyline Medical sent the…

AIPT

Precision Therapeutics

$1.00

0.01 (1.01%)

SKLN

Ticker changed to AIPT

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$64.84

1.39 (2.19%)

12:05
05/25/18
05/25
12:05
05/25/18
12:05
Options
Kellogg call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

12:05
05/25/18
05/25
12:05
05/25/18
12:05
General news
Treasury Option Action: some bullish positioning »

Treasury Option Action:…

GIFI

Gulf Island Fabrication

$10.40

-0.05 (-0.48%)

11:56
05/25/18
05/25
11:56
05/25/18
11:56
Hot Stocks
Gulf Island Fabrication awarded 3300HP towboat newbuild project with option »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$102.96

0.86 (0.84%)

, TWX

Time Warner

$94.04

-0.22 (-0.23%)

11:54
05/25/18
05/25
11:54
05/25/18
11:54
Hot Stocks
Box Office Battle: 'Solo' looking to shoot first, take out 'Deadpool 2' »

Disney's (DIS) Han…

DIS

Disney

$102.96

0.86 (0.84%)

TWX

Time Warner

$94.04

-0.22 (-0.23%)

VIAB

Viacom

$27.69

0.4 (1.47%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$24.50

1.17 (5.02%)

LGF.B

Lionsgate

$23.05

1 (4.54%)

SNE

Sony

$46.56

0.11 (0.24%)

VIA

Viacom

$32.45

0.6 (1.88%)

FOX

21st Century Fox

$38.81

0.31 (0.81%)

FOXA

21st Century Fox

$39.25

0.32 (0.82%)

CMCSA

Comcast

$31.99

0.35 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKTR

Nektar

$80.14

-0.44 (-0.55%)

11:53
05/25/18
05/25
11:53
05/25/18
11:53
Conference/Events
Nektar to hold 2018 ASCO Investor Event »

In conjunction with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

CELG

Celgene

$79.23

-0.25 (-0.31%)

11:50
05/25/18
05/25
11:50
05/25/18
11:50
Conference/Events
Celgene to hold analyst and investor event from ASCO Annual Meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 02

    Jun

  • 03

    Jun

  • 05

    Jun

  • 13

    Jun

NKE

Nike

$72.43

0.29 (0.40%)

11:50
05/25/18
05/25
11:50
05/25/18
11:50
Options
Notable spread in Nike as shares reach new highs »

Notable spread in Nike as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AFSI

AmTrust

$13.76

0.035 (0.26%)

11:49
05/25/18
05/25
11:49
05/25/18
11:49
Hot Stocks
Icahn says ISS recommends shareholders vote against AmTrust going-private deal »

Carl Icahn issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRLCY

L'Oreal

$0.00

(0.00%)

11:46
05/25/18
05/25
11:46
05/25/18
11:46
Hot Stocks
L'Oreal to acquire Pulp Riot Hair Color »

L'Oreal announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$38.70

2.72 (7.56%)

11:45
05/25/18
05/25
11:45
05/25/18
11:45
Options
Roku Inc (Class A Stock) call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
05/25/18
05/25
11:45
05/25/18
11:45
Conference/Events
Barclays biopharmaceutical analyst to hold an analyst/industry conference call »

U.S. Biopharmaceuticals…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.